What oral medication can be prescribed to reduce pain and facilitate cervical softening for intrauterine device (IUD) insertion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Medications for IUD Insertion

The oral medications that can be prescribed for IUD insertion are NSAIDs (specifically naproxen 550 mg or ketorolac 20 mg taken 1-2 hours before) for pain management, and oral benzodiazepines (midazolam 10 mg taken 30-60 minutes before, or lorazepam 1-2 mg sublingual, or diazepam 5-10 mg taken 20-30 minutes before) for anxiety management. 1

Pain Management: NSAIDs

For pain control, prescription-strength oral naproxen 550 mg taken 1 to 2 hours beforehand or ketorolac 20 mg oral given 1 to 2 hours before is recommended by the most recent 2025 expert guidelines 1.

The evidence shows:

  • Naproxen 500 mg reduced pain during IUD placement in multiparous women and showed clinically significant reduction in pain at 5 and 15 minutes after placement 1
  • Oral ketorolac 20 mg taken 40-60 minutes before reduced pain both during and 10 minutes after placement 1
  • Ibuprofen has NOT been shown to reduce pain during IUD placement, though it may help with post-procedure pain 1, 2

Important caveat: Tramadol 50 mg taken 1 hour prior was more effective than naproxen in one study, but as an opioid it requires pre-planning, cannot be given with benzodiazepines, and the patient needs transportation to/from the appointment 1.

Anxiety Management: Benzodiazepines

For patients with significant anxiety, oral midazolam 10 mg taken 30 to 60 minutes beforehand is preferred due to its fast onset, short half-life (1.5-2.5 hours), and favorable safety profile 1.

Alternatives include:

  • 1-2 mg sublingual lorazepam taken 20-30 minutes before
  • 5-10 mg oral diazepam taken 20-30 minutes before 1

Critical note: While benzodiazepines don't directly reduce pain, they alleviate patient anxiety. There have been no studies specifically investigating oral anxiolytics for reducing IUD placement pain 1.

What About Misoprostol for Cervical Softening?

Misoprostol is NOT recommended for routine use 1, 3. The 2025 guidelines are clear: most studies and reviews do not support routine misoprostol use to decrease pain with IUD placement 1.

Reserve misoprostol only for:

  • Cases of previously failed placement
  • Selected patients with risk factors for failed insertion (e.g., known cervical stenosis) 1

When used, the evidence supports:

  • 200 mcg vaginal misoprostol given at 10 and 4 hours prior improved successful placement for patients with previously failed attempts 1
  • 400 mcg vaginal misoprostol given 4 hours prior decreased patient-reported pain and clinician-reported difficulty in nulliparous patients, but increased post-procedure cramping 1, 4

The downsides are significant: misoprostol probably results in a 2.14-fold increase in preplacement abdominal pain/cramping and a 1.76-fold increase in diarrhea 3.

Common Pitfalls to Avoid

  1. Don't prescribe ibuprofen expecting pain reduction during insertion - it doesn't work for that purpose 1, 2
  2. Don't combine tramadol with benzodiazepines - respiratory depression risk 1
  3. Don't routinely use misoprostol - side effects outweigh benefits for routine insertions 1, 3
  4. Don't forget timing - NSAIDs need 1-2 hours to reach peak levels, benzodiazepines need 20-60 minutes depending on type 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.